Alexandra Rohracher, MD

Alexandra RohracherDr. Alexandra Rohracher is a neurologist, who specialized in epileptology throughout her residency at the University hospital Salzburg, Austria. As a member of Prof. Trinka´s research group, her previous scientific work mainly focused on clinical studies on diagnosis and treatment of status epilepticus, epilepsy surgery, as well as antiepileptic drug treatment in pharmacoresistant epilepsy. In September 2018, she will join Birgit Frauscher´s lab to investigate predictors identifying patients who will benefit from SEEG regarding subsequent surgery, based on non-invasive presurgical work up.


EEG diploma of the Austrian League against Epilepsy 06/2014

Specialist Examination Neurology 04/2016


Scientific Work:

Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data. Rohracher A, Zimmermann G, Villanueva V et al. Epilepsia. 2018 Jul 25. doi: 10.1111/epi.14520.

Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit – a single center audit on 30 patients. Rohracher A, Kalss G, Neuray C et al. Epilepsia. 2018 Jul 25. doi: 10.1111/epi.14494

Status epilepticus in the elderly-A retrospective study on 120 patients. Rohracher A, Reiter DP, Brigo F, et al. Epilepsy Res. 2016 Nov;127:317-323.

Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data. Rohracher A, Kalss G, Leitinger M et al. Ther Adv Neurol Disord. 2016 Nov;9(6):445-453.

Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy. Rohracher A, Brigo F, Höfler J et al. Expert Opin Pharmacother. 2016 Jul;17(10):1403-11. doi: 10.1080/14656566.2016.1195810.

Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit. Rohracher A, Höfler J, Kalss G, Leitinger M, Kuchukhidze G, Deak I, Dobesberger J, Novak H, Pilz G, Zerbs A, Trinka E. Epilepsy Behav. 2015 Aug;49:354-8. doi: 10.1016/j.yebeh.2015.04.005.

Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study. Leitinger M, Trinka E, Gardella E, Rohracher A, Kalss G, Qerama E, Höfler J, Hess A, Zimmermann G, Kuchukhidze G, Dobesberger J, Langthaler PB, Beniczky S. Lancet Neurol. 2016 Sep;15(10):1054-62. doi: 10.1016/S1474-4422(16)30137-5

The ILAE definition of drug resistant epilepsy and its clinical applicability compared with “older” established definitions. Alexandra Rohracher, Judith Dobesberger, Claudia A. Granbichler, Julia Höfler, Giorgi Kuchukhidze, Martin Ortler, Iris Unterberger, Gerald Walser, Aljoscha Thomschewski, Eugen Trinka. Journal of Epileptology • 2015 • 23 • ID 893672

Pharmacologic treatment of status epilepticus. Trinka E, Höfler J, Leitinger M, Rohracher A, Kalss G, Brigo F. Expert Opin Pharmacother. 2016;17(4):513-34. doi: 10.1517/14656566.2016.1127354. Review.

Outcome prediction and reporting in nonconvulsive status epilepticus. Leitinger M, Kalss G, Kuchukhidze G, Höfler J, Dobesberger J, Rohracher A, Trinka E. Seizure. 2015 Dec;33:99. doi: 10.1016/j.seizure.2015.08.003

Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus--approach to clinical application. Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, Höfler J, Hess Lindberg-Larsen A, Kuchukhidze G, Dobesberger J, Langthaler PB, Trinka E. Epilepsy Behav. 2015 Aug;49:158-63. doi: 10.1016/j.yebeh.2015.05.007

Back to top